191 related articles for article (PubMed ID: 32966238)
1. Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma.
Xie Z; Lun Y; Li X; He Y; Wu S; Wang S; Sun J; He Y; Zhang J
Aging (Albany NY); 2020 Sep; 12(18):18163-18180. PubMed ID: 32966238
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
Front Endocrinol (Lausanne); 2021; 12():646793. PubMed ID: 34122331
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
BMC Cancer; 2020 Nov; 20(1):1143. PubMed ID: 33238942
[TBL] [Abstract][Full Text] [Related]
4. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
Zheng L; Li S; Zheng X; Guo R; Qu W
Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
7. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma.
Xia F; Wang W; Jiang B; Chen Y; Li X
Cancer Manag Res; 2019; 11():1249-1262. PubMed ID: 30799952
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of KIF-12 Functioning as a Tumour Suppressor in Papillary Thyroid Carcinoma.
Gao L; Liu R; Xia Y; Pan A; Shi X; Ma L; Ji J; Hu Y; Li X; An Y; Luo N; Liang Z; Zhou L; Jiang Y
J Cancer; 2024; 15(8):2206-2213. PubMed ID: 38495495
[No Abstract] [Full Text] [Related]
11. F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.
Luo JH; Zhang XX; Sun WH
Aging (Albany NY); 2022 Apr; 14(8):3687-3704. PubMed ID: 35483340
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ITGA3 as a Biomarker of Progression and Recurrence in Papillary Thyroid Carcinoma.
Zhang G; Li B; Lin Y
Front Oncol; 2021; 11():614955. PubMed ID: 35174063
[TBL] [Abstract][Full Text] [Related]
13. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X
Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer.
Xia Y; Jiang X; Huang Y; Liu Q; Huang Y; Zhang B; Mei Z; Xu D; Shi Y; Tu W
Front Endocrinol (Lausanne); 2022; 13():895428. PubMed ID: 35757399
[TBL] [Abstract][Full Text] [Related]
16. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
[No Abstract] [Full Text] [Related]
17. HIF1A overexpression predicts the high lymph node metastasis risk and indicates a poor prognosis in papillary thyroid cancer.
Zhao YX; Yang Z; Ma LB; Wang F; Wang Y; Xiang C
Heliyon; 2023 Mar; 9(3):e14714. PubMed ID: 36994412
[TBL] [Abstract][Full Text] [Related]
18. ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.
Lin X; Wang ZY; Xue G; Qin XJ; Wu JF; Zhang G
J Cancer; 2021; 12(13):3997-4010. PubMed ID: 34093805
[No Abstract] [Full Text] [Related]
19. Insight of novel biomarkers for papillary thyroid carcinoma through multiomics.
Liu W; Zhu J; Wu Z; Yin Y; Wu Q; Wu Y; Zheng J; Wang C; Chen H; Qazi TJ; Wu J; Zhang Y; Liu H; Yang J; Lu D; Zhang X; Ai Z
Front Oncol; 2023; 13():1269751. PubMed ID: 37795451
[TBL] [Abstract][Full Text] [Related]
20. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]